| Authors: |
Sattar N; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Linetzky B; Eli Lilly and Company, Indianapolis, Indiana, USA. Electronic address: linetzky_bruno@lilly.com., Ruotolo G; Eli Lilly and Company, Indianapolis, Indiana, USA., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada., Sourij H; Cardiometabolic Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria., Wang H; TechData Service Company, LLC, King of Prussia, Pennsylvania, USA., Vanderman K; Syneos Health, Inc, Morrisville, North Carolina, USA., Wilson JM; Eli Lilly and Company, Indianapolis, Indiana, USA., Griffin RM; Eli Lilly and Company, Indianapolis, Indiana, USA., Stefanski A; Eli Lilly and Company, Indianapolis, Indiana, USA., Ridker PM; Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiovascular Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. |
